Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LGALS9 | O00182 | 1/20 | 0.31 |
| ▸ | LGALS1 | P09382 | 1/20 | 0.31 |
| ▸ | LGALS3 | P17931 | 1/20 | 0.31 |
| ▸ | LGALS7; LGALS7B | P47929 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL13381107 | 0.75 | SERPINC1 (0.30) | — | |
| SCHEMBL13381078 | 0.72 | LGALS8 (0.35) | LGALS9LGALS1LGALS3LGALS7; LGALS7B | |
| SCHEMBL13381029 | 0.71 | PTPN1 (0.33) | — | |
| SCHEMBL13381015 | 0.69 | PTPN1 (0.37) | — | |
| SCHEMBL13381027 | 0.68 | PTPN1 (0.33) | — | |
| SCHEMBL13381075 | 0.67 | CA1 (0.37) | — | |
| SCHEMBL13381069 | 0.65 | TNF (0.35) | — | |
| SCHEMBL13381064 | 0.65 | NT5E (0.36) | — | |
| SCHEMBL13381081 | 0.65 | PTPN1 (0.38) | — | |
| SCHEMBL12174017 | 0.64 | LGALS8 (0.40) | LGALS9LGALS3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | ENDOTIS PHARMA (FR) | 2010-04-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100081708-A1 | ANTICOAGULANT COMPOUNDS | SERPINC1, F2, FUT5 | LGALS9 177/4885LGALS1 195/4885LGALS3 157/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.